Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Baidu Health Partners with Shanghai Epiprobe for Cancer Early Screening

February 1, 2025
CompanyDeals

Pharmaniaga Partners with JD.com to Enter China Market

February 1, 2025
CompanyDrug

Eli Lilly’s Peresolimab and LOXO-783 Gain Tacit Clinical Trial Approvals in China

February 1, 2025
CompanyDrug

Hua Medicine Launches Dorzagliatin, a First-in-Class Diabetes Drug, in China

February 1, 2025
CompanyMedical Device

Yiming and Hexaell’s HepaCure Biocolumn Receives IND Approval for HBV-Induced Liver Failure

February 1, 2025
CompanyDrug

Yiming and Vitalgen’s Gene Therapy VGR-R01 Receives CDE Approval for Bietti Crystalline Dystrophy

February 1, 2025
CompanyDrug

LianBio’s TP-03 Begins Phase III Trial for Demodectic Blepharitis in China

February 1, 2025
CompanyDrug

Ascletis Files IND Application for COVID-19 Oral Inhibitor ASC11 with FDA

February 1, 2025
CompanyDrug

RemeGen’s Telitacicept Shows Positive Results in Phase II Myasthenia Gravis Study

February 1, 2025
CompanyDeals

Immunochina Pharmaceuticals Raises Funds for Gene Therapy Development

February 1, 2025
CompanyMedical Device

BGI Genomics Receives NMPA Approval for Chromosome Aneuploidy Detection Kit

February 1, 2025
CompanyPolicy / Regulatory

NMPA Suspends GSK’s Avodart Amid Inspection Findings

February 1, 2025
1 2 … 22 23 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up